A comprehensive view of Diabetes. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

State of Kansas files lawsuit alleging Sanofi-Aventis, Eli Lilly, Novo Nordisk and middlemen conspired to drive up insulin prices; lawsuit alleges that insulin selling for US$300 to US$700 cost less than US$5 to make

India approves AstraZeneca’s Dapagliflozin for diabetes patients with chronic kidney disease; the drug significantly reduces risk of sustained estimated glomerular filtration rate, cardiovascular deaths, hospitalizations due to heart failure

Global drug delivery devices market expected to hit US$124.8B by 2029, with CAGR growth of 5.6% from 2022-2029 driven by increase in chronic diseases, including diabetes; diabetes expected to affect 783 million people worldwide by 2045

GlobalData: Continuous glucose monitoring devices could become main solution for US diabetes population if FDA's proposed changes to reimbursement go ahead; majority of diabetes patients currently have to undergo invasive self-testing several times a day

Studies find cinnamon extracts carry antimicrobial properties, contribute to slow down of nervous system degeneration, can regulate blood glucose; cinnamon is used to support health of patients with HIV, Alzheimer's, Multiple Sclerosis and diabetes

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count